Litigation Details for AstraZeneca LP v. InvaGen Pharmaceuticals Inc. (D. Del. 2015)

✉ Email this page to a colleague

Docket	⤷ Sign Up	Date Filed	2015-10-30
Court	District Court, D. Delaware	Date Terminated	2018-03-09
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Parties	ASTRAZENECA PHARMACEUTICALS LP
Patents	6,251,910; 6,525,060; 7,250,419; 7,265,124; 8,425,934
Attorneys	Lynne Terrebonne
Firms	Kratz & Barry LLP
Link to Docket	External link to docket

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2015-10-30	1		AstraZeneca’s U.S. Patent Nos. 6,251,910 (“the ’910 patent”), 6,525,060 (“the ’060 patent”), ME1 21399823v…7,250,419 (“the ’419 patent”), 7,265,124 (“the ’124 patent”), and 8,425,934 (“the ’934 patent”) that are listed… This is an action for patent infringement arising under the patent laws of the United States, … PATENTS-IN-SUIT 20. On June 26, 2001, the U.S. Patent and Trademark Office…copy of the ’910 patent is attached hereto as Exhibit A. The claims of the ’910 patent are valid and enforceable	External link to document
2018-03-15	28		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,251,910; 6,525,060; 7,250,419…2015 9 March 2018 1:15-cv-01001 830 Patent None District Court, D. Delaware	External link to document
2015-10-30	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,251,910; 6,525,060; 7,250,419… 30 October 2015 1:15-cv-01001 830 Patent None District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document